Back to search

Article

Inhibition of Mitochondrial Carrier Homolog 2 (MTCH2) Suppresses Tumor Invasion and Enhances Sensitivity to Temozolomide in Malignant Glioma

2020-12-31

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Malignant glioma exerts a metabolic shift from oxidative phosphorylation (OXPHOs) to aerobic glycolysis, with suppressed mitochondrial functions. This phenomenon offers a proliferation advantage to tumor cells and decrease mitochondria-dependent cell death. However, the underlying mechanism for mitochondrial dysfunction in glioma is not well elucidated. MTCH2 is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
92b2c5c5-9b34-5c7d-9e84-b699fc6c6bf9
DOI
10.21203/rs.3.rs-53540/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of Mitochondrial Carrier Homolog 2 (MTCH2) Suppresses Tumor Invasion and Enhances Sensitivity to Temozolomide in Malignant GliomaDOI 10.21203/rs.3.rs-53540/v3
Select a neighboring publication to make it the new centre.